FDA Seeks To Clarify Status Of Systems For Health IT, Remote Monitoring
This article was originally published in The Gray Sheet
Executive Summary
FDA is proposing to put software that passively collects and stores medical device data into a lower risk category. The move is intended to clear up confusion about the regulatory status of the products, which are central to health IT and remote monitoring efforts